Skip to main content
Caplight Logo









HydRegen

HydRegen

Private
OxfordEnergy & Sustainabilityhttps://hydregenoxford.com

Last Round

Series A

Oct 14, 2026

Total Funding Raised

$15.67M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

HydRegen is a biotechnology company that develops bio-based manufacturing technologies designed to produce clean, safe, and sustainable chemicals.

Sector

Energy & Sustainability

Verticals

Biotechnology, Clean Manufacturing, Smart Manufacturing

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service, Usage-Based SaaS

AI Layer

Non-AI

Keywords

biocatalysisgreen chemistryenzyme catalysthydrogenationsustainable manufacturingbiotechchemical manufacturingdecarbonizationdrop-in technologysynthetic biologyindustrial biotechclean techprocess intensification

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

HydRegen Comparables

Compare HydRegen with similar companies based on industry and business-model similarity.

HydRegen comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
FabricNano
87%
Imperagen
80%
Anodyne Chemistries
79%

HydRegen Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AOct 14, 2026
Series AApr 26, 2023
SeedMar 1, 2022

Key People

Founding team and executive leadership

Sarah Cleary

Chief Scientific Officer, Co-Founder

Founding Team

Holly Reeve

CEO Co-founder

Founding Team

Matthew Hodges

Chief Operating Officer

Executive Team

HydRegen Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 14, 2026

    Raised $2M in early funding.

  • Jun 21, 2026

    Monthly visitors increased 444% from 332 to 1.8K.

Recent news

Latest coverage and updates

  • hiresOct 16, 2026

    HydRegen Limited appoints Pierre Moreau as Process Engineer, Chemistry, strengthening its process development and scale-up capabilities as it advances its biocatalytic technologies toward commercial manufacturing on Oct 16th '26.

  • is_developingOct 14, 2026

    HydRegen Limited is developing enzyme catalysts that can operate inside existing manufacturing equipment.

  • receives_financingOct 14, 2026

    On Oct 14th '26 in United Kingdom, HydRegen Limited receives $8M in the first close of its Series A financing led by Genoa Ventures, with participation from Clean Growth Fund and First Imagine! Ventures, to expand customer work and accelerate adoption of its biocatalysis technology.

  • hiresOct 13, 2026

    HydRegen Limited hires Mark Eldridge as Synthetic Biologist to strengthen its biological capabilities and support the scale-up of its biocatalytic technologies in the United Kingdom on Oct 13th '26.

  • hiresOct 7, 2026

    HydRegen Limited appoints Kat Usachova as Analytical and DSP Chemist in United Kingdom on Oct 7th '26, strengthening its analytical and downstream processing capabilities as it advances its biocatalytic hydrogenation platform toward commercial deployment.

HydRegen Filings

Explore SEC and related filing metadata, where available.

HydRegen filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about HydRegen's valuation, stock price, and market status.

Is HydRegen a public or private company?

HydRegen is a private company.

What is the current stock price of HydRegen?

HydRegen is a private company, so its shares have no public market price. Caplight tracks HydRegen's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is HydRegen worth (valuation)?

Valuation information for HydRegen is not publicly available.

Can I buy HydRegen stock?

HydRegen shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was HydRegen's last funding round?

HydRegen's most recent funding round was Series A on October 14, 2026.

Who are the main investors in HydRegen?

Key investors in HydRegen include Genoa Ventures, Clean Growth Investment Management, UK Innovation & Science Seed Fund.

Will HydRegen IPO soon?

No public IPO plans have been announced for HydRegen.

How can I track HydRegen secondary market activity?

Caplight tracks bids, offers, and trades in HydRegen's shares on secondary markets.

Firmographic Details

HeadquartersOxford
Employee Range15
Year Founded2020
Last FundingOct 14, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?